PT  - JOURNAL ARTICLE
AU  - Suhail, Yasir
AU  - Afzal, Junaid
AU  - Kshitiz,
TI  - Incorporating and Addressing Testing Bias Within Estimates of Epidemic Dynamics for SARS-CoV-2
AID  - 10.1101/2020.05.02.20088120
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.05.02.20088120
4099  - http://medrxiv.org/content/early/2020/05/06/2020.05.02.20088120.short
4100  - http://medrxiv.org/content/early/2020/05/06/2020.05.02.20088120.full
AB  - The disease burden of SARS-CoV-2 as measured by tests from various countries present varying estimates of infection and fatality rates. Models based on these acquired data may suffer from systematic errors and large estimation variances due to the biases associated with testing and lags between the infection and death counts. Here, we present an augmented compartment model to predict epidemic dynamics while explicitly modeling for the sampling bias involved in testing. Our simulations show that sampling biases in favor of patients with higher disease manifestation could significantly affect direct estimates of infection and fatality rates calculated from the numbers of confirmed cases and deaths, and serological testing can partially mitigate these biased estimates. We further recommend a strategy to obtain unbiased estimates, calculating the dependence of expected confidence on a randomized sample size, showing that relatively small sample sizes can provide statistically significant estimates for SARS-CoV-2 related death rates.Competing Interest StatementThe authors have declared no competing interest.Funding StatementUniversity of Connecticut Health Faculty startup funds were used.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNo new patient data is generated, but all models will be made available upon publication in peer reviewed journals.